ドラッグデリバリー市場 Vol.�U：埋め込み型・注入型

Abstract

Fueled by the promise of needle-free mechanisms for vaccine distribution and other pharmaceutical uses, the implantable/injectable drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to continued growth.

With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products. The implantable/injectable delivery drug market is a expected to grow to over $12 billion by 2010.

Kalorama' s Drug Delivery Markets. Edition 2 Volume II: Implantable / Injectable Systems, the second volume of Kalorama' s popular series focusing on global drug delivery systems markets, provides the definitive break down of the market for implantable / injectable delivery system markets.

The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:

• Needle-Free delivery systems
• Implantable delivery systems
• Targeted Delivery systems
• Sustained-release drug delivery

This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:

• Detailed Profiles of Key Companies in Implantable/Injectable Delivery and Brief Round-Up of smaller players
• Current Revenue and Forecasts to 2010 By Needle-Free and Other Implantable/Injectable Segments
• Extensive Discussion of Implantable/Injectable Trends and Developments
• New Products in Development

Kalorama' s trusted information-gathering process provides most accurate study of the implantable/injectable delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders. Product managers, marketing managers, business development executives, advertising agency or investment firm executives, and information and research center librarians are among the individuals who will find this report on the implantable/injectable delivery drug market -- as well as the whole Kalorama Series on Drug Delivery Systems essential.

Table of Contents

Chapter one: Executive Summary

• Market Drivers
• Market Size and Growth
  • Total Injectable/Implantable Drug Delivery Market
  • The Injectable/Implantable Drug Delivery Only Market
• Competitor and Market Analysis

Chapter two: Introduction

• Scope and Methodology
• Reasons for Injectable/Implantable Drug Delivery Systems
• History of Injectable/Implantable Drug Delivery
• Phases of Drug Action
• Needle-Free Drug Delivery
  • Major Applications
  • Safety Concerns
  • Products
• Implantable Drug Delivery
  • Mechanisms
  • Applications
  • Products
• Sustained-Release Drug Delivery
  • Products
• Targeted Injection Drug Delivery
  • Products

Chapter three: Trends and Developments

• Drivers of the Injectable/Implantable Drug Delivery Market
  • Biologics
  • Cancer
• Pen injectors
• Proprietary Product Development
• Delivery Systems Placement Trends
• Therapeutic Trends
• Incorporation of Technology
• Nanotechnology
• Drug Delivery Development
  • Microsphere Technology
  • Targeted Technology
  • MicroChip Technology
  • NanoParticles
  • Protein-Coated Microcrystal Technology
  • Needle-Free Delivery Development
  • Selected Products in Development

Chapter four: Market Size and Growth

• The Total Injectable/Implantable Drug Delivery Market
• Injectable/Implantable Delivery Technology Only Market

chapter five: Competitive and Market Analysis

• Competitive Landscape
• Market Analysis

Chapter six: Company Profiles

• Alkermes, Inc.
• ALZA Corp.
• Antares Pharma, Inc.
• Bioject Medical Technologies, Inc.
• CyDex, Inc.
• MGI Pharma, Inc
• Nektar Therapeutics
• PowderMed Pharmaceuticals Plc
• SkyePharma Plc
• Zogenix Corporation

Chapter seven: Companies in Brief

• AP Pharma
• Baxter BioPharma Solutions
• ImaRx Therapeutics Inc.
• PR Pharmaceuticals, Inc.
• pSivida
• QLT USA, Inc

Appendix: Company Directory

TABLE OF EXHIBITS

Chapter one: Executive Summary

• Figure 1-1: The Worldwide Market for Injectable/Implantable
• Drug Delivery Technology and Pharmaceuticals 2002-2010

Chapter two: Introduction

• Table 2-1: Sequence of Drug Action

Chapter three: Trends and Developments

• Table 3-1: Select Products in Early Stage Development by Drug
• Delivery Companies

Chapter four: Market Size and Growth

• Table 4-1: Worldwide Market for Injectable/Implantable Drug Delivery Technology and Pharmaceuticals 2002-2010
• Figure 4-1: Worldwide Market for Injectable/Implantable Drug Delivery Technology and Pharmaceuticals 2002-2010
• Table 4-2: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery by Type 2002-2010
• Figure 4-2: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery by Type 2002-2010
• Table 4-3: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2002-2010
• Figure 4-3: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2006
• Figure 4-4: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2010
• Table 4-4: Worldwide Market for Injectable/Implantable Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
• Table 4-5: Injectable/Implantable Drug Delivery Systems: Worldwide Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
• Figure 4-5: Injectable/Implantable Drug Delivery Systems Worldwide Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
• Figure 4-6: Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010

chapter five: Competitive and Market Analysis

• Table 5-1: Leading Suppliers of Injectable/Implantable Drug Delivery Technology
• Figure 5-1: Cost per Million Injections by Injector Type